Index S&P 500
P/E 47.24
EPS (ttm) 5.63
Insider Own 9.02%
Shs Outstand 739.20M
Perf Week -0.31%
Market Cap 192.25B
Forward P/E 30.81
EPS next Y 8.64
Insider Trans -0.31%
Shs Float 657.05M
Perf Month 1.10%
Income 4.20B
PEG 6.77
EPS next Q 1.56
Inst Own 82.95%
Short Float 0.97%
Perf Quarter -0.66%
Sales 24.82B
P/S 7.75
EPS this Y -0.14%
Inst Trans -0.22%
Short Ratio 2.21
Perf Half Y 4.75%
Book/sh 68.92
P/B 3.86
EPS next Y 14.16%
ROA 5.19%
Short Interest 6.39M
Perf Year 16.86%
Cash/sh 3.29
P/C 80.98
EPS next 5Y 6.98%
ROE 8.36%
52W Range 182.09 - 281.70
Perf YTD 15.07%
Dividend Est. 0.97 (0.37%)
P/FCF 37.68
EPS past 5Y 11.31%
ROI 6.35%
52W High -5.50%
Beta 0.84
Dividend TTM 1.05 (0.39%)
Quick Ratio 1.04
Sales past 5Y 8.35%
Gross Margin 59.21%
52W Low 46.19%
ATR (14) 4.69
Dividend Ex-Date Jun 28, 2024
Current Ratio 1.43
EPS Y/Y TTM -34.06%
Oper. Margin 21.49%
RSI (14) 49.63
Volatility 1.81% 1.47%
Employees 63000
Debt/Eq 0.36
Sales Y/Y TTM -18.25%
Profit Margin 16.94%
Recom 1.74
Target Price 287.86
Option/Short Yes / Yes
LT Debt/Eq 0.33
EPS Q/Q -17.74%
Payout 16.45%
Rel Volume 1.13
Prev Close 264.71
Sales Surprise 2.82%
EPS Surprise 9.32%
Sales Q/Q -19.76%
Earnings Jul 23 BMO
Avg Volume 2.89M
Price 266.20
SMA20 -0.74%
SMA50 2.04%
SMA200 7.39%
Trades
Volume 3,250,323
Change 0.56%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-28-24 Initiated
Wells Fargo
Equal Weight
$280
Jun-03-24 Resumed
Jefferies
Buy
$295
Apr-17-24 Upgrade
HSBC Securities
Hold → Buy
$280
Jan-24-24 Downgrade
Barclays
Overweight → Equal Weight
$240
Dec-18-23 Initiated
HSBC Securities
Hold
Dec-13-23 Resumed
Wolfe Research
Peer Perform
Dec-07-23 Downgrade
Goldman
Buy → Neutral
$215 → $205
Jul-19-23 Initiated
Raymond James
Outperform
$270
May-01-23 Initiated
SVB Securities
Outperform
$300
Apr-26-23 Downgrade
BofA Securities
Buy → Neutral
$310 → $250
Apr-18-23 Upgrade
Wells Fargo
Equal Weight → Overweight
$275 → $285
Jan-05-23 Downgrade
Credit Suisse
Outperform → Neutral
$315 → $300
Dec-14-22 Initiated
Deutsche Bank
Buy
$310
Oct-24-22 Downgrade
The Benchmark Company
Buy → Hold
$325
Aug-25-22 Initiated
Credit Suisse
Outperform
$340
Aug-17-22 Resumed
Bernstein
Outperform
$330 → $340
Jul-20-22 Initiated
UBS
Buy
$297
Jun-01-22 Upgrade
RBC Capital Mkts
Sector Perform → Outperform
$299 → $310
Apr-25-22 Downgrade
Wells Fargo
Overweight → Equal Weight
$265
Jan-11-22 Initiated
Bernstein
Outperform
$365
Show Previous Ratings
Sep-04-24 04:30PM
08:00AM
Sep-03-24 11:32PM
Aug-26-24 05:30PM
Aug-22-24 11:30AM
08:00AM
Loading…
Aug-21-24 08:00AM
Aug-19-24 08:00AM
Aug-16-24 11:28AM
Aug-07-24 08:00AM
05:30AM
Aug-02-24 07:01PM
Jul-30-24 07:30AM
Jul-26-24 11:41PM
05:46PM
Jul-25-24 02:28PM
09:00AM
Loading…
09:00AM
Jul-24-24 08:00AM
01:31AM
(Thomson Reuters StreetEvents)
01:01AM
Jul-23-24 06:33PM
04:25PM
(Investor's Business Daily)
12:22PM
12:21PM
12:00PM
11:50AM
10:57AM
09:59AM
09:30AM
08:39AM
07:10AM
06:07AM
Loading…
06:07AM
(Associated Press Finance)
06:00AM
Jul-19-24 12:10PM
Jul-18-24 10:19AM
05:44AM
Jul-17-24 07:30AM
Jul-16-24 12:00PM
09:40AM
07:30AM
Jul-13-24 05:56PM
03:29PM
Jul-11-24 07:50AM
07:30AM
Jul-10-24 08:43AM
08:00AM
Jul-09-24 03:00AM
Jul-05-24 06:48AM
Jul-04-24 07:47AM
Jun-26-24 08:00AM
Jun-24-24 04:30PM
10:24AM
Jun-19-24 07:30AM
Jun-17-24 09:27AM
Jun-14-24 10:00AM
07:26AM
Jun-13-24 05:35AM
Jun-12-24 08:00AM
Jun-11-24 09:40AM
Jun-09-24 09:00AM
Jun-07-24 08:20AM
08:09AM
Jun-06-24 10:08AM
Jun-05-24 07:00AM
May-30-24 04:06AM
May-29-24 08:00AM
May-23-24 11:30AM
May-17-24 07:01PM
May-15-24 10:43AM
08:00AM
May-09-24 01:13PM
07:00AM
May-08-24 09:00AM
May-07-24 04:45PM
04:15PM
May-06-24 02:50PM
May-05-24 08:19AM
May-03-24 09:06AM
May-01-24 08:00AM
Apr-26-24 03:09PM
Apr-25-24 07:00PM
Apr-24-24 09:52AM
03:01AM
01:02AM
Apr-23-24 10:17PM
(Thomson Reuters StreetEvents) +7.21%
04:41PM
12:21PM
(The Wall Street Journal)
12:07PM
(Associated Press Finance)
11:39AM
11:33AM
(Investor's Business Daily)
11:29AM
10:53AM
10:44AM
09:30AM
07:31AM
07:10AM
06:59AM
06:55AM
06:26AM
06:07AM
(Associated Press Finance)
06:00AM
Danaher Corp. engages in the design, manufacture, and marketing of professional, medical, industrial, and commercial products and services. It operates through the following segments: Biotechnology, Life Sciences, Diagnostics, and Environmental and Applied Solutions. The Biotechnology segment includes the bioprocessing and discovery and medical businesses and offers a range of tools, consumables, and services. The Life Sciences segment offers a range of instruments and consumables to study the basic building blocks of life, including DNA and RNA. The Diagnostics segment offers clinical instruments, reagents, consumables, software, and services used to diagnose disease and make treatment decisions. The Environmental and Applied Solution segment offers products and services that help protect important resources and keep global food and water supplies safe. The company was founded by Steven M. Rales and Mitchell P. Rales in 1984 and is headquartered in Washington, DC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Couchara Georgeann SVP, Human Resources Aug 26 '24 Sale 268.37 952 255,483 4,212 Aug 27 05:04 PM Couchara Georgeann Officer Aug 26 '24 Proposed Sale 268.37 952 255,483 Aug 26 04:40 PM Glenstone Foundation See Remarks Aug 13 '24 Proposed Sale 267.20 47,937 12,808,766 Aug 13 04:05 PM Blair Rainer President & CEO Jul 31 '24 Sale 280.00 9,007 2,521,960 97,983 Aug 02 05:00 PM FILLER LINDA Director Aug 01 '24 Option Exercise 59.34 3,928 233,088 45,077 Aug 02 05:00 PM FILLER LINDA Director Aug 01 '24 Sale 279.50 3,928 1,097,876 41,149 Aug 02 05:00 PM McGrew Matthew EVP & Chief Financial Officer Aug 01 '24 Option Exercise 62.85 16,172 1,016,410 45,579 Aug 02 05:00 PM McGrew Matthew EVP & Chief Financial Officer Aug 01 '24 Sale 279.84 16,172 4,525,555 29,407 Aug 02 05:00 PM McGrew Matthew Officer Aug 01 '24 Proposed Sale 279.84 16,172 4,525,555 Aug 01 04:28 PM FILLER LINDA Director Aug 01 '24 Proposed Sale 279.50 3,928 1,097,876 Aug 01 12:27 PM Blair Rainer Officer Jul 31 '24 Proposed Sale 280.00 9,007 2,521,960 Jul 31 04:26 PM Ellis Brian W Senior Vice President - GC Jul 25 '24 Sale 275.16 9,600 2,641,536 20,230 Jul 26 05:03 PM Raskas Daniel SVP - Corporate Development Jul 25 '24 Sale 270.51 14,507 3,924,352 23,595 Jul 26 05:03 PM Zerhouni Elias A. Director Jul 15 '24 Option Exercise 52.56 3,289 172,870 37,483 Jul 16 05:01 PM SCHWIETERS JOHN T Director Jul 15 '24 Option Exercise 52.56 3,289 172,870 19,808 Jul 16 05:00 PM King William SVP, Strategic Development May 15 '24 Option Exercise 50.37 12,623 635,821 55,208 May 17 05:10 PM Blair Rainer President & CEO May 16 '24 Sale 265.00 9,005 2,386,325 106,990 May 17 05:08 PM Blair Rainer President & CEO May 14 '24 Option Exercise 59.91 19,085 1,143,435 135,080 May 15 05:00 PM Blair Rainer President & CEO May 14 '24 Sale 255.00 19,085 4,866,675 115,995 May 15 05:00 PM McGrew Matthew EVP & Chief Financial Officer May 10 '24 Option Exercise 61.25 25,174 1,541,794 45,338 May 13 05:01 PM McGrew Matthew EVP & Chief Financial Officer May 10 '24 Sale 253.05 46,377 11,735,856 29,407 May 13 05:01 PM SPOON ALAN G Director May 02 '24 Option Exercise 52.56 3,289 172,870 116,910 May 03 05:03 PM SPOON ALAN G Director May 02 '24 Sale 243.58 708 172,455 116,202 May 03 05:03 PM Weidemanis Joakim Executive Vice President Apr 25 '24 Option Exercise 58.48 22,433 1,311,882 112,845 Apr 26 05:00 PM Weidemanis Joakim Executive Vice President Apr 25 '24 Sale 250.46 22,433 5,618,569 90,412 Apr 26 05:00 PM Ellis Brian W Senior Vice President - GC Apr 24 '24 Sale 250.01 4,000 1,000,040 29,830 Apr 25 05:00 PM Blair Rainer President & CEO Apr 24 '24 Option Exercise 59.91 38,170 2,286,870 154,165 Apr 25 05:00 PM Blair Rainer President & CEO Apr 24 '24 Sale 249.22 47,175 11,756,725 115,995 Apr 25 05:00 PM Raskas Daniel SVP - Corporate Development Feb 26 '24 Option Exercise 58.48 23,757 1,389,309 61,859 Feb 27 05:01 PM Raskas Daniel SVP - Corporate Development Feb 26 '24 Sale 252.00 23,757 5,986,764 38,102 Feb 27 05:01 PM LOHR WALTER G Director Feb 15 '24 Option Exercise 52.56 3,289 172,870 17,418 Feb 16 05:01 PM LOHR WALTER G Director Feb 15 '24 Sale 251.15 3,289 826,032 14,129 Feb 16 05:01 PM Couchara Georgeann SVP, Human Resources Feb 13 '24 Option Exercise 70.71 2,622 185,414 6,022 Feb 14 05:00 PM Couchara Georgeann SVP, Human Resources Feb 13 '24 Sale 242.67 2,622 636,290 4,244 Feb 14 05:00 PM List Teri Director Feb 06 '24 Option Exercise 52.56 3,289 172,870 23,015 Feb 08 05:00 PM List Teri Director Feb 06 '24 Sale 248.32 3,289 816,724 19,726 Feb 08 05:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite